111 related articles for article (PubMed ID: 29293251)
1. Stable nanoconjugates of transferrin with alloyed quaternary nanocrystals Ag-In-Zn-S as a biological entity for tumor recognition.
Matysiak-Brynda E; Bujak P; Augustin E; Kowalczyk A; Mazerska Z; Pron A; Nowicka AM
Nanoscale; 2018 Jan; 10(3):1286-1296. PubMed ID: 29293251
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages.
Pati R; Sahu R; Panda J; Sonawane A
Sci Rep; 2016 Apr; 6():24184. PubMed ID: 27113139
[TBL] [Abstract][Full Text] [Related]
3. New Unsymmetrical Bisacridine Derivatives Noncovalently Attached to Quaternary Quantum Dots Improve Cancer Therapy by Enhancing Cytotoxicity toward Cancer Cells and Protecting Normal Cells.
Pilch J; Matysiak-Brynda E; Kowalczyk A; Bujak P; Mazerska Z; Nowicka AM; Augustin E
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17276-17289. PubMed ID: 32208730
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
5. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-conjugated cationic Ag
Duman FD; Erkisa M; Khodadust R; Ari F; Ulukaya E; Acar HY
Nanomedicine (Lond); 2017 Oct; 12(19):2319-2333. PubMed ID: 28875744
[TBL] [Abstract][Full Text] [Related]
7. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
8. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
Zhu B; Zhang H; Yu L
Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
[TBL] [Abstract][Full Text] [Related]
9. Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells.
Li S; Amat D; Peng Z; Vanni S; Raskin S; De Angulo G; Othman AM; Graham RM; Leblanc RM
Nanoscale; 2016 Sep; 8(37):16662-16669. PubMed ID: 27714111
[TBL] [Abstract][Full Text] [Related]
10. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
12. Dendronized nanoconjugates of lysine and folate for treatment of cancer.
Jain K; Gupta U; Jain NK
Eur J Pharm Biopharm; 2014 Aug; 87(3):500-9. PubMed ID: 24698808
[TBL] [Abstract][Full Text] [Related]
13. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
[TBL] [Abstract][Full Text] [Related]
14. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
[TBL] [Abstract][Full Text] [Related]
15. Foliate-Targeting Quantum Dots-
Pilch J; Kowalik P; Kowalczyk A; Bujak P; Kasprzak A; Paluszkiewicz E; Augustin E; Nowicka AM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163186
[TBL] [Abstract][Full Text] [Related]
16. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier.
Nowicka AM; Kowalczyk A; Donten M; Krysinski P; Stojek Z
Anal Chem; 2009 Sep; 81(17):7474-83. PubMed ID: 19663451
[TBL] [Abstract][Full Text] [Related]
17. Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems.
Makwana H; Mastrotto F; Magnusson JP; Sleep D; Hay J; Nicholls KJ; Allen S; Alexander C
Biomacromolecules; 2017 May; 18(5):1532-1543. PubMed ID: 28350442
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells.
Johari-Ahar M; Barar J; Alizadeh AM; Davaran S; Omidi Y; Rashidi MR
J Drug Target; 2016; 24(2):120-33. PubMed ID: 26176269
[TBL] [Abstract][Full Text] [Related]
19. A novel type of quantum dot-transferrin conjugate using DNA hybridization mimics intracellular recycling of endogenous transferrin.
Banerjee A; Grazon C; Pons T; Bhatia D; Valades-Cruz CA; Johannes L; Krishnan Y; Dubertret B
Nanoscale; 2017 Oct; 9(40):15453-15460. PubMed ID: 28976518
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
